FeLV and feline lymphoma: association and viral classification in a 2018 review
Viruses · 2018
In plain language
A 2018 review describes an association between FeLV and several fatal diseases in cats, including lymphoma. The supplied text does not say how much lymphoma risk increases or explain how this cancer develops. The review also covers methods used to classify the virus and study its transmission and ability to cause disease. The authors identify the influence of endogenous FeLV and the cat's genetics as topics for future research.
Scientific detail
The review “A Retrospective Examination of Feline Leukemia Subgroup Characterization: Viral Interference Assays to Deep Sequencing,” published in Viruses in 2018 (doi: 10.3390/v10010029), describes an association between FeLV and multiple fatal disease syndromes in cats, including lymphoma. The claims in the supplied object represent level C evidence from a review, not a new experimental result. The supplied abstract does not establish a causal mechanism, quantify lymphoma risk, or describe the underlying study designs.
The review examines how viral interference assays, Sanger sequencing, PCR, and next-generation sequencing have sequentially defined FeLV classification, transmission, and disease-inducing potential. This describes the review's scope; it does not demonstrate that a particular subgroup or genetic alteration causes lymphoma or leukemia. Although its discussion of molecular pathology and disease-inducing potential is relevant to oncogenesis, the supplied text provides no specific oncogenic mechanism, subgroup-specific cancer risk, or leukemia outcome.
The authors identify the influences of endogenous FeLV and host genetics as opportunities for future research. Identifying these priorities does not specify their mechanisms or demonstrate their contribution to feline oncogenesis. The supplied object does not report a sample size or detail the review's limitations.
What we know
The review describes an association between FeLV and several fatal disease syndromes in cats, including lymphoma. It also discusses the successive contributions of different methods to viral classification and the study of transmission and disease-inducing potential. These level C claims describe knowledge and topics covered in a review, not new experimental findings.
What we don't know
The supplied text does not establish a causal mechanism for lymphoma, quantify its risk, or describe the underlying study designs. It also provides no subgroup-specific cancer risks, leukemia outcomes, or demonstration of a contribution from endogenous FeLV or host genetics to feline oncogenesis. The review's sample size and limitations are not reported.
Evidence
EvidenceLevel C — Preliminary evidenceConfidence 100/100
FeLV is associated with multiple fatal disease syndromes in cats, including lymphoma.
Excerpt verified in the source — verbatim, in the source's own language“Feline leukemia virus (FeLV) was the first feline retrovirus discovered, and is associated with multiple fatal disease syndromes in cats, including lymphoma.”
This is an explicit review-level statement of association with feline lymphoma. The supplied abstract does not establish a causal mechanism, quantify lymphoma risk, or describe the underlying study designs.
EvidenceLevel C — Preliminary evidenceConfidence 100/100
The review discusses how viral interference assays, Sanger sequencing, PCR, and next-generation sequencing have sequentially defined FeLV classification, transmission, and disease-inducing potential.
Excerpt verified in the source — verbatim, in the source's own language“In this review, we discuss how FeLV classification, transmission, and disease-inducing potential have been defined sequentially by viral interference assays, Sanger sequencing, PCR, and next-generation sequencing.”
This describes the review's scope rather than a new experimental result. It does not establish that any particular subgroup or genetic alteration causes lymphoma or leukemia.
EvidenceLevel C — Preliminary evidenceConfidence 100/100
The authors identify the influences of endogenous FeLV and host genetics as opportunities for future FeLV research.
Excerpt verified in the source — verbatim, in the source's own language“In particular, we highlight the influences of endogenous FeLV and host genetics that represent FeLV research opportunities on the near horizon.”
This identifies research priorities without specifying their mechanisms or demonstrating their contribution to feline oncogenesis.
Provenance
Source: A Retrospective Examination of Feline Leukemia Subgroup Characterization: Viral Interference Assays to Deep Sequencing.
AVA